SKP2 and metastatic melanoma: Betulinic acid, a plant-derived Skp2 inhibitor, has been demonstrated to exhibit antitumor activity and low cytotoxicity in Phase 1 clinical trials (NCT00701987 and NCT030904511) against cutaneous metastatic melanoma.